MA54374A - Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication - Google Patents

Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication

Info

Publication number
MA54374A
MA54374A MA054374A MA54374A MA54374A MA 54374 A MA54374 A MA 54374A MA 054374 A MA054374 A MA 054374A MA 54374 A MA54374 A MA 54374A MA 54374 A MA54374 A MA 54374A
Authority
MA
Morocco
Prior art keywords
enzymaticly
composition
making
outer layer
delayed release
Prior art date
Application number
MA054374A
Other languages
English (en)
Inventor
Gonzalez Roberto Carlos Bravo
Carsten Markus Füller
Felipe Varum
Rochow Laetitia Von
Original Assignee
Tillotts Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=64661233&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA54374(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag
Publication of MA54374A publication Critical patent/MA54374A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA054374A 2018-12-07 2019-12-05 Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication MA54374A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP18211152.6A EP3662901B1 (fr) 2018-12-07 2018-12-07 Formulation de médicaments à une liberation ralentie avec une couche extérieure comprenant un polymère dégradable par des enzymes, sa composition et son processus de production

Publications (1)

Publication Number Publication Date
MA54374A true MA54374A (fr) 2022-03-16

Family

ID=64661233

Family Applications (1)

Application Number Title Priority Date Filing Date
MA054374A MA54374A (fr) 2018-12-07 2019-12-05 Formulation de médicament à libération retardée comprenant une couche externe avec un polymère dégradable par voie enzymatique, sa composition et son procédé de fabrication

Country Status (25)

Country Link
US (1) US12370146B2 (fr)
EP (2) EP3662901B1 (fr)
JP (1) JP7391966B2 (fr)
KR (1) KR102802080B1 (fr)
CN (1) CN113226292A (fr)
AR (1) AR117681A1 (fr)
AU (2) AU2019392854B2 (fr)
BR (1) BR112021010914A2 (fr)
CA (2) CA3281153A1 (fr)
CL (1) CL2021001472A1 (fr)
CO (1) CO2021008683A2 (fr)
CR (1) CR20210366A (fr)
EA (1) EA202191597A1 (fr)
ES (1) ES3002632T3 (fr)
GE (1) GEP20247608B (fr)
IL (1) IL283718B1 (fr)
JO (1) JOP20210136A1 (fr)
MA (1) MA54374A (fr)
MX (2) MX2021006603A (fr)
PH (1) PH12021551292A1 (fr)
SG (1) SG11202105691RA (fr)
TW (1) TWI865473B (fr)
UA (1) UA128938C2 (fr)
WO (1) WO2020115255A1 (fr)
ZA (1) ZA202103676B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240041779A1 (en) * 2020-12-08 2024-02-08 Triastek, Inc. Delayed sustained-release oral drug dosage forms of a janus kinase (jak) inhibitor and methods of use
US20250319027A1 (en) * 2022-07-01 2025-10-16 Vitakey Inc. Nutraceutical particles
JP2026513283A (ja) * 2023-03-31 2026-04-23 トリアステック，インコーポレーテッド 結腸送達のための経口薬物剤形ならびにその使用および製造方法
CN118948789B (zh) * 2024-08-05 2025-04-01 山东丰金生物医药有限公司 一种稳定的美沙拉秦结肠定位释放组合物及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812490D0 (en) 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
GB8926639D0 (en) 1989-11-24 1990-01-17 Agricultural & Food Res Delayed release formulations
US5422121A (en) 1990-11-14 1995-06-06 Rohm Gmbh Oral dosage unit form
US5656290A (en) 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5914132A (en) 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5482718A (en) 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
CN1239425A (zh) * 1996-11-15 1999-12-22 普罗克特和甘保尔公司 供结肠释放的具有多层肠溶聚合物包衣的药剂
GB9722426D0 (en) 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
GB9724186D0 (en) 1997-11-14 1998-01-14 British Tech Group Low temperature coatings
FI20000780L (fi) 2000-04-03 2001-10-04 Novasso Oy Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
GB2367002A (en) 2000-09-25 2002-03-27 British Sugar Plc Coating composition
GB0203421D0 (en) 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US7670627B2 (en) 2002-12-09 2010-03-02 Salvona Ip Llc pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US9149439B2 (en) 2005-03-21 2015-10-06 Sandoz Ag Multi-particulate, modified-release composition
DE102005032806A1 (de) 2005-07-12 2007-01-18 Röhm Gmbh Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
FR2899061B1 (fr) 2006-03-31 2009-07-31 Cid Lines Nv Composition d'hygiene et/ou comestique et/ou desinfectante contenant au moins un agent anti-parasitaire repulsif et/ou insectifuge.
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
AU2012247013B2 (en) * 2006-04-13 2016-01-14 University College London Colonic drug delivery formulation
PL2152250T3 (pl) 2007-05-07 2020-06-15 Evonik Röhm Gmbh Stałe postaci dawkowania zawierające otoczkę dojelitową o przyspieszonym uwalnianiu leku
WO2009105409A2 (fr) * 2008-02-19 2009-08-27 Mc Neil-Ppc, Inc. Compositions revêtues par immersion contenant un amidon ayant une teneur élevée en amylose
WO2012129551A1 (fr) 2011-03-23 2012-09-27 Ironshore Pharmaceuticals & Development, Inc. Procédés et compositions destinés au traitement du trouble déficitaire de l'attention
CU24343B1 (es) 2012-04-30 2018-05-08 Tillotts Pharma Ag Formulación de fármaco de liberación retardada
SI2659881T1 (en) 2012-04-30 2018-03-30 Tillotts Pharma Ag Formulation of the delayed release medicinal product
EA032504B1 (ru) 2013-10-29 2019-06-28 Тиллоттс Фарма АГ Лекарственный препарат с отсроченным высвобождением и его применение для доставки лекарственного средства
CN105412904A (zh) 2014-06-17 2016-03-23 深圳翰宇药业股份有限公司 利那洛肽肠溶缓释微丸胶囊制剂及其制备方法和用途
CN108601744B (zh) 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
CN105832691B (zh) 2016-05-31 2018-10-02 深圳市健元医药科技有限公司 一种度拉糖肽结肠定位缓释制剂及其制备方法
EP3257501A1 (fr) * 2016-06-14 2017-12-20 Tillotts Pharma AG Forme galénique unitaire multiple comprenant un noyau avec différentes unités de coeur recouvertes par un matériau muco-adhésif et un revêtement noyau gastro-résistant
WO2018005606A1 (fr) 2016-06-28 2018-01-04 Synthetic Biologics, Inc. Protection du microbiome contre les antibiotiques oraux
JP7328207B2 (ja) 2017-08-09 2023-08-16 アルビレオ・アクチボラグ コレスチラミンペレット、経口コレスチラミン製剤、及びそれらの使用
EP3662902B1 (fr) 2018-12-07 2024-07-31 Tillotts Pharma AG Formulation pour la liberation de médicaments dans le côlon
EP3662900A1 (fr) 2018-12-07 2020-06-10 Tillotts Pharma AG Formulation d'administration de médicament colonique

Also Published As

Publication number Publication date
CA3281153A1 (en) 2025-10-31
EP3662901C0 (fr) 2025-01-01
AU2025220793A1 (en) 2025-09-11
TWI865473B (zh) 2024-12-11
CO2021008683A2 (es) 2021-08-19
CL2021001472A1 (es) 2021-12-24
EP3662901B1 (fr) 2025-01-01
KR20210100663A (ko) 2021-08-17
US12370146B2 (en) 2025-07-29
JP2022511119A (ja) 2022-01-28
EP3890710A1 (fr) 2021-10-13
US20220023222A1 (en) 2022-01-27
EA202191597A1 (ru) 2021-08-30
AU2019392854B2 (en) 2025-06-26
KR102802080B1 (ko) 2025-05-02
IL283718A (en) 2021-07-29
MX2021006603A (es) 2021-08-24
IL283718B1 (en) 2026-06-01
BR112021010914A2 (pt) 2021-08-24
CN113226292A (zh) 2021-08-06
GEP20247608B (en) 2024-03-11
ZA202103676B (en) 2022-10-26
SG11202105691RA (en) 2021-06-29
TW202038968A (zh) 2020-11-01
WO2020115255A1 (fr) 2020-06-11
JP7391966B2 (ja) 2023-12-05
MX2024012397A (es) 2024-11-08
EP3662901A1 (fr) 2020-06-10
PH12021551292A1 (en) 2022-03-28
JOP20210136A1 (ar) 2023-01-30
AU2019392854A1 (en) 2021-07-08
ES3002632T3 (en) 2025-03-07
CA3122013A1 (fr) 2020-06-11
AR117681A1 (es) 2021-08-25
UA128938C2 (uk) 2024-12-04
CR20210366A (es) 2021-11-23

Similar Documents

Publication Publication Date Title
EP3591749A4 (fr) Électrode multicouche et son procédé de fabrication
EP3417924A4 (fr) Matériau polymère, film, revêtement, procédé de préparation associé et application
EP3452026A4 (fr) Procédés de fabrication, compositions et applications médicales de produits pharmaceutiques à base de cannabis administrés par voie orale
EP3476968A4 (fr) Acier trempé à chaud de faible densité et son procédé de fabrication
EP3392369A4 (fr) Film de revêtement, son procédé de fabrication et appareil de pvd
EP3741421A4 (fr) Micro-aiguille implantable et son procédé de fabrication
EP3381469A4 (fr) Conjugué anticorps-médicament anti-erbb2 et composition à base de celui-ci, procédé de préparation associé et leur application
EP3480840A4 (fr) Film semi-conducteur d'oxyde et son procédé de fabrication
FR3053696B1 (fr) Composition de polyamide semi-cristallin de haute temperature de transition vitreuse pour materiau composite, son procede de fabrication et ses utilisations
EP3660060A4 (fr) Polymère fluoré, composition d'agent de démoulage et procédé de démoulage
EP3486275A4 (fr) Film d'étanchéité, et procédé de fabrication de celui-ci
EP3627212A4 (fr) Composition de lentille de contact, et lentille de contact et son procédé de fabrication
ZA202103676B (en) Delayed release drug formulation comprising an outerlayer with an enzymaticyally degradable polymer, its composition and its method of manufacturing
EP3488699A4 (fr) Composition antibactérienne, film antibactérien, matériau de base avec film antibactérien, procédé de fabrication de film antibactérien, et procédé de fabrication de matériau de base avec film antibactérien
EP3553581A4 (fr) Structure de lentille, son procédé de fabrication et caméra
EP3907293A4 (fr) Biopuce, procédé de fabrication et application correspondants
EP3939575A4 (fr) Microparticules de plga, formulation à libération prolongée de celles-ci et leur procédé de fabrication
EP3495394A4 (fr) Procédé de fabrication de polymère à base de diène conjugué modifié, et procédé de fabrication de composition de polymère
EP3507621A4 (fr) Détecteur de rayonnement et son procédé de fabrication
KR102015640B9 (ko) 양극회전형 엑스선관용 회전양극타겟 제작용 몰드장치 및 이를 이용한 회전양극타겟 제조방법
EP3521464A4 (fr) Matériau coulissant et son procédé de fabrication, et élément coulissant
EP3565000A4 (fr) Élément d'imagerie à semiconducteur et son procédé de fabrication
EP3608438A4 (fr) Cible en siliciure de tungstène et son procédé de fabrication
EP3621659A4 (fr) Composition d'administration de médicament et procédé de fabrication
EP3641730A4 (fr) Particule et composition pharmaceutique comprenant un composé de camptothécine insoluble ayant une double structure c ur-coque et son procédé de fabrication